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EDITORIAL

The Renal Amalgam: Where Renal Pathology Fits

A

n amalgam is composed of metallic alloys that somehow by virtue of their individual properties fit
together and become more than the sum of its constituent
parts: this is the essence of nephrology. Recalling that the
kidney performs a myriad of functions, it is only apropos
that the discipline has required a coalition of several constituencies: electrolyticians, endocrinologists, dialyticians, hypertensionologists, and renal pathologists. This
coalition, somewhat amorphous at first, congealed to
become what we now acknowledge as the discipline of
nephrology.
Renal pathologists themselves only coalesced as a club
in November 1977, during an American Society of
Nephrology meeting at the Washington Hilton hotel.1
However, they had been around for years and may be
traced back to at least 1914, the year of Theodor Volhard’s
seminal publication on glomerulonephritis, nephrosis,
and hypertensive nephrosclerosis.2 Subsequently, the
club met at the annual meetings of the American Society
of Nephrology, National Kidney Foundation, and the
United States and Canadian Academy of Pathology
under the leadership of Presidents Conrad Pirani and
Robert Heptinstall. Club status was shed in March 1993
with rebirth as the Renal Pathology Society (RPS), and
2 of its more than 400 members—from more than 30
countries—serve as coast-to-coast Guest Editors of this
issue of Advances in Chronic Kidney Disease: Cynthia
Nast from the University of California, Los Angeles
(RPS Past President, 2003) and Laura Barisoni from
New York University. Long overdue and 16 RPS presidents later, this is the first time that this journal has
been stewarded by direct purveyors of kidney pathology.
Renal pathologists have contributed mightily to this
understanding and at all levels—clinically and pathophysiologically. The importance of an understanding of
the fundamentals of kidney pathology to our discipline
is underscored as an intrinsic requirement of any nephrology training program. Lamentably, it is still never
enough. However, a solution has been provided, and
mini renal pathology courses are provided at many of

the top nephrology society meetings. They are wildly
popular and perennially oversubscribed. There is no
‘‘standing room only.’’
In this issue, ‘‘The Role of Glomerular Disease in Progressive Renal Disease,’’ the Guest Editors have compiled
8 articles that inform the reader on what is most poorly understood in nephrology, namely, glomerular disorders.
Before 1950, our appreciation of glomerulopathies lay
primarily within the advanced disease of autopsied specimens. Until today’s routine technique of periodic acidSchiff staining appeared, histological examination had
been severely hampered.3,4 Now, we can more fully
correlate the differential contributions of the cells that
are contained in the glomeruli to renal pathology.
Phenotypical alterations correspond with biomolecular
changes and are manifest as hematuria and proteinuria
(see ACKD Volume 18, No. 4) and may be characterized,
in part, by the urinary proteome (see ACKD Volume 17,
No. 6).
Drs. Bomback and Markowitz initiate this series with
a discussion of renal biopsy in elderly patients. The kidney biopsy, now routine, was once fraught with danger
until proven safe and effective by Iversen and Brun, in
their milestone publication of the aspiration technique
during intravenous pyelography.5 Notably, success was
present in 42 of the original 66 patients. Now, much
more safely done, renal biopsy should not be eschewed
based on age alone.
When examining the causes of ESRD worldwide, it is
frighteningly apparent that type 2 diabetes mellitus and
hypertension do not always constitute approximately
70% of the causes of ESRD, as they do in the United
States. Infection-related glomerular disorders play a distressingly prominent role in other parts of the world,
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where diabetes is less of a problem, and Dr. Nast will expound on the topic of postinfectious glomerulonephritis.
The term ‘‘glomerulosclerosis’’ is often used by clinical
nephrologists as a diagnosis rather than a morphological
description. The reasons and correction of this error will
be discussed by Dr. Barisoni, as she provides mechanistic
insights into the role of the podocyte with regard to repair
and progression of this descriptive lesion that often portends progression of CKD.
Drs. Vernon and Cook provide a salient discussion of
complement. Activation of this primordial defense system
is described as a host mediator of tubulointerstitial compartmental damage. Given that the tubulointerstitium is
engaged in crosstalk with its upstream glomerular counterpart, complement-mediated inflammation here is a harbinger of progression. Vernon and Cook’s discussion is
complemented by the review of Dr. Satirapoj, which
focuses on mechanisms through which glomerular damage initiates and perpetuates tubulointerstitial damage,
rather than the converse situation, whereby an inflamed
tubulointerstitium injures glomeruli.6 Likely, both are
true with conflation of injury, as the inverse and contrapositive circumstances clearly are observed microscopically.
The final 3 disease-specific articles review disorders for
which there is a large amount of emerging knowledge.
Dr. Cohen (RPS Past President, 1997) reviews the collagenofibrotic glomerulopathies as proteinuric disorders and
their characterization by immunostaining of type III collagen and ultrastructural appearance. Drs. Haas and Reich
cogently discuss the requirement for means other than

clinical parameters to independently predict prognosis
in IgA nephropathy. Here, renal biopsy may more greatly
inform the clinician, and the utility of kidney biopsy scoring systems in IgA nephropathy is critically reviewed.
Finally, exciting observations regarding the pathogenesis
of membranous nephropathy and the prospect of a nonproteinuric method to monitor this in situ immune complex disorder are provided by Drs. Segal and Choi.
Clearly, nephrology represents the amalgam of multiple groups of differing expertise, all focused on the function and diseases of the kidney. Each constituent of the
amalgam holds it together, including those properties
of renal pathologists, who provide a light where clinicians cannot see.
Jerry Yee, MD
Editor
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